BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1711304)

  • 1. [Tumor markers--personal experience. Multidisciplinary treatment of disseminated germ cell tumor in full use of tumor markers].
    Tobisu K
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1221-6. PubMed ID: 1711304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and treatment of testicular cancer.
    Hesketh PJ
    Hosp Pract (Off Ed); 1987 Sep; 22(9A):87-90, 93-102. PubMed ID: 2484998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of tumor markers in the treatment of germ cell tumor].
    Niwakawa M; Tobisu K
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1159-65. PubMed ID: 11525037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
    Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
    Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum markers in germ cell neoplasms.
    Bartlett NL; Freiha FS; Torti FM
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1245-60. PubMed ID: 1723408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T; Goepel M; Seeber S; Rübben H
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of markers AFP, HCG and LDH in advanced germ cell tumors before and after cytostasis resp.
    Jaeger N; Vahlensieck W
    Prog Clin Biol Res; 1985; 203():107-16. PubMed ID: 2421323
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular mixed germ cell tumor with polyembryoma component in brothers.
    Bakaris S; Resim S; Tunali N
    Pediatr Dev Pathol; 2005; 8(1):92-7. PubMed ID: 15803215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in clinical therapeutics: testicular cancer.
    Bergmann KA
    Clin Pharm; 1987 Sep; 6(9):693-706. PubMed ID: 2445518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular germ cell tumors: diagnosis, management, and the potential for cure.
    Katz ME; Grosbach AB; Wein A; Glick JH
    Cancer Clin Trials; 1978; 1(4):247-71. PubMed ID: 93029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of advanced germ-cell tumors of the testis.
    Fléchon A; Rivoire M; Droz JP
    Nat Clin Pract Urol; 2008 May; 5(5):262-76. PubMed ID: 18398406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy].
    Gerl A; Clemm C; Kohl P; Niedermaier J; Schalhorn A
    Med Klin (Munich); 1994 May; 89(5):240-4. PubMed ID: 7519720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
    Malagón HD; Valdez AM; Moran CA; Suster S
    Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.